AlzChem Group AG: Re-placement of shares successfully completed
The share re-placement of AlzChem was successfully completed.
Trostberg, June 9, 2021 - The shareholders LIVIA Corporate Development SE and HDI Vier CE GmbH informed AlzChem Group AG that the re-placement of shares to institutional investors as announced on May 19, 2021, was successfully completed. Shares totalling 16.2% of the share capital were re-placed. LIVIA Corporate Development SE is still holding approximately 29,6% and HDI Vier CE GmbH approximately 12% of the share capital.
AlzChem Group AG expressly welcomes the increase in the free float to approximately 43%. This will contribute to increasing the liquidity and thus the attracitivity of AlzChem Group AG shares.
AlzChem is a globally active specialty chemicals company that is one of the market leaders in its fields of activity, also in the international segment. With its broad product range, AlzChem benefits in a special way from the four very different global megatrends of energy efficiency, sustainability, healthy aging and population growth, insofar as efficiency in food production can be decisively improved. Here, AlzChem products offer attractive solutions in a wide range of different applications.
The company sees interesting growth prospects for itself in particular in the areas of human and animal nutrition, pharmaceuticals, agriculture, fine chemicals, metallurgy and renewable energies. The company’s broad product range includes dietary supplements, plant growth regulators and precursors for corona tests.
AlzChem employs around 1,630 people at four production sites in Germany and Sweden, and at two sales companies in the USA and China. In 2020, AlzChem generated consolidated sales of around EUR 379 million and EBITDA of around EUR 53.8 million.